Uncategorized
Germany’s Medical Cannabis Boom: Prices Drop Below $4.20/Gram, Prescriptions Surge 1,000%
Germany’s medical cannabis market in 2024 saw record affordability, 1,000% prescription growth, and digital access advancements. read more
Fed Set To Signal No Rush To Cut Rates As Wall Street Awaits Policy Clarity
Fed expected to keep rates steady, but Wall Street desperate for clarity on when next cut will come. Markets hoping for a dovish signal, but Powell may not deliver. Odds of two cuts in 2025 at 93%, with $4 payout for single cut and $6 for no cuts. read more
Expert Outlook: Lululemon Athletica Through The Eyes Of 31 Analysts
Latest Ratings for LULU Date Firm Action From To Jan 2022 Barclays Maintains Overweight Jan 2022 Morgan Stanley Maintains Equal-Weight Jan 2022 Telsey Advisory Group Maintains Outperform View More Analyst Ratings for LULU View the Latest Analyst Ratings read more
Pfizer Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Latest Ratings for PFE Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Jan 2022 Wells Fargo Maintains Overweight Jan 2022 B of A Securities Upgrades Neutral Buy View More Analyst Ratings for PFE View the Latest Analyst Ratings read more
Where TransUnion Stands With Analysts
Latest Ratings for TRU Date Firm Action From To Feb 2022 Stifel Maintains Buy Feb 2022 JP Morgan Maintains Overweight Feb 2022 Credit Suisse Maintains Neutral View More Analyst Ratings for TRU View the Latest Analyst Ratings read more
Visa Stock Moves Higher As Company Becomes First Partner Of Musk’s XMoney: What’s Going On?
Visa Inc (NYSE:V) is set to become the first partner of social media platform X’s Money account as the Elon Musk-owned company makes a push into payments. Visa shares were trading slightly higher at last check. read more
Jim Cramer Endorses Bitcoin As A ‘Great Thing,’ But Guess What He Had To Say About MicroStrategy
CNBC’s “Mad Money” host Jim Cramer on Tuesday publicly endorsed Bitcoin (CRYPTO: BTC), urging investors to include the cryptocurrency in their portfolios read more